Celkeran 5 mg (Chlorambucil)

Detailed Description — Celkeran 5 mg (Chlorambucil)

Celkeran 5 mg contains chlorambucil, a chemotherapy medication classified as an alkylating agent. It is primarily used to treat chronic lymphocytic leukemia (CLL), Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, and sometimes other cancers as determined by an oncologist.

Chlorambucil works by damaging DNA in rapidly dividing cells, preventing cancer cells from multiplying and inducing cell death. Its oral formulation allows convenient home administration under strict medical supervision.

How Celkeran Works

• Chlorambucil is an alkylating agent, which binds to DNA

• Causes cross-linking of DNA strands, preventing replication

• Slows the proliferation of rapidly dividing cancer cells

• Leads to apoptosis (programmed cell death) in malignant cells

• Non-cancerous cells are also affected, which can cause side effects

Uses of Celkeran 5 mg

Celkeran is prescribed for:

• Chronic lymphocytic leukemia (CLL)

• Hodgkin’s and non-Hodgkin’s lymphoma

• Sometimes used in other hematologic malignancies

• Occasionally used in certain autoimmune conditions (off-label, under supervision)

It is not effective for solid tumors or non-cancerous infections.

Dosage & Administration

• Typical starting dose for adults: 0.1–0.2 mg/kg per day, taken orally

• Capsules should be swallowed whole with water, preferably at the same time daily

• Take with or without food

• Treatment duration varies based on cancer type, response, and tolerance

• Dose adjustments may be needed for elderly patients or those with liver/kidney impairment

Always follow your oncologist’s prescription, as dosage varies greatly between patients.

Benefits of Celkeran 5 mg

• Effective in slowing progression of leukemia and lymphomas

• Oral administration allows home-based treatment

• Can be used in combination with other chemotherapy agents for enhanced efficacy

• Provides targeted suppression of cancer cell growth

Possible Side Effects

Common side effects:

• Nausea and vomiting

• Loss of appetite

• Fatigue and weakness

• Diarrhea or constipation

• Hair thinning or hair loss

Serious side effects:

• Bone marrow suppression (leading to low red cells, white cells, or platelets)

• Increased susceptibility to infections

• Liver toxicity

• Allergic reactions (rare)

• Secondary cancers with long-term use (rare but possible)

Patients should report any fever, unusual bruising, persistent fatigue, or infections immediately.

Precautions & Warnings

• Avoid pregnancy and breastfeeding during treatment

• Monitor blood counts and liver/kidney function regularly

• Avoid live vaccines during treatment

• Minimize exposure to infections due to immune suppression

• Inform your doctor about all medications, supplements, and health conditions

Drug Interactions

Chlorambucil may interact with:

• Other chemotherapy drugs (additive toxicity)

• Immunosuppressants

• Medications that affect blood counts or liver metabolism

Always consult your oncologist before starting new medications.

Storage Instructions

• Store at 20–25°C in a dry place

• Keep capsules in original packaging

• Protect from moisture and light

• Keep out of reach of children

• Do not use after the expiration date

External Reference

For more detailed information about chlorambucil, visit:
🔗 https://www.drugs.com/mtm/chlorambucil.html

Frequently Asked Questions (FAQ)

1. What is Celkeran 5 mg used for?
It is used to treat chronic lymphocytic leukemia, Hodgkin’s lymphoma, and non-Hodgkin’s lymphoma.

2. How does chlorambucil work?
It damages the DNA of cancer cells, preventing them from multiplying and inducing cell death.

3. Can it be taken at home?
Yes, it is an oral chemotherapy drug, but only under strict medical supervision.

4. Are there common side effects?
Yes, including nausea, fatigue, hair thinning, and gastrointestinal discomfort.

5. What are serious side effects?
Bone marrow suppression, liver toxicity, infections, and rare secondary cancers.

6. Can it be taken during pregnancy?
No, chlorambucil is teratogenic and must be avoided during pregnancy and breastfeeding.

7. How is treatment monitored?
Regular blood tests and liver/kidney function tests are required to monitor safety and effectiveness.